Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
Active Funding Opportunities
| Title |
Notice Number |
Organization(s) |
Release
Date |
Expiration
Date |
Activity
Code(s) |
| NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) |
RFA-HD-23-026 |
NICHD
|
May 23, 2022 |
Aug 11, 2022
|
P01
|
| Notice of Special Interest: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data |
NOT-PM-22-002 |
OD,
NCATS,
NCCIH,
NCI,
NEI,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NINR,
NLM,
OAR,
OBSSR,
ODSS,
ORWH,
RM,
SGMRO
|
May 20, 2022 |
Jul 6, 2022
|
333
|
| Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
PAR-22-167 |
NCATS,
NIAMS,
NICHD,
NIDCR,
NIGMS,
NIMHD,
OBSSR,
ORWH
|
May 9, 2022 |
Oct 18, 2024
|
UG3/UH3
|
| NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional) |
RFA-HD-23-017 |
NICHD
|
May 6, 2022 |
Aug 12, 2022
|
U24
|
| Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) |
RFA-AG-23-024 |
NIA
|
May 6, 2022 |
Oct 21, 2022
|
R01
|
| Notice of Special Interest (NOSI): IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity |
NOT-OD-22-125 |
OD
|
May 5, 2022 |
Jul 17, 2022
|
R01, R03, R21
|
| Notice of Special Interest (NOSI): Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) |
NOT-MD-22-015 |
NIMHD
|
May 3, 2022 |
Jun 28, 2022
|
333
|
| Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA |
NOT-AA-22-012 |
NIAAA
|
Apr 29, 2022 |
Mar 6, 2024
|
R01, R03, R21, K99/R00
|
| Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities |
NOT-HD-22-003 |
NICHD,
NIAAA,
NIDA,
NINDS,
OBSSR,
ORWH
|
Apr 19, 2022 |
Jun 6, 2024
|
333
|
| Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed) |
RFA-OD-22-011 |
OD,
NIA,
NIAMS,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NLM
|
Apr 6, 2022 |
Jun 1, 2022
|
U24
|
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-22-005 |
NIEHS
|
Mar 29, 2022 |
Jun 7, 2022
|
333
|
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-22-005 |
NIEHS
|
Mar 29, 2022 |
Jun 7, 2022
|
333
|
| Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities |
NOT-HD-22-002 |
NICHD,
NIDA,
NIEHS,
NINDS,
OBSSR,
ORWH
|
Mar 28, 2022 |
Jun 6, 2024
|
R01, R21
|
| Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) |
RFA-MD-22-008 |
NIMHD,
NCI
|
Mar 22, 2022 |
Nov 14, 2022
|
R01
|
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) |
PAR-22-138 |
NIMH,
NIAAA,
NIEHS,
ORWH
|
Mar 15, 2022 |
May 8, 2025
|
R21
|
| Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
PAR-22-137 |
NIMH,
NIAAA,
NIEHS,
ORWH
|
Mar 15, 2022 |
May 8, 2025
|
R01
|
| Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment |
NOT-EY-22-010 |
NEI
|
Feb 4, 2022 |
Mar 9, 2024
|
R41/R42, R15, 333, R01, R43/R44, R21
|
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) |
PAR-22-112 |
NIMH
|
Jan 31, 2022 |
Dec 24, 2022
|
R01
|
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) |
PAR-22-112 |
NIMH
|
Jan 31, 2022 |
Dec 24, 2022
|
R01
|
| Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) |
PAR-22-113 |
NIMH
|
Jan 31, 2022 |
Dec 24, 2022
|
R01
|
| Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups |
NOT-HL-22-010 |
NHLBI
|
Jan 31, 2022 |
May 8, 2025
|
R01
|
| Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy |
NOT-HL-23-003 |
NHLBI
|
Jan 21, 2022 |
Jul 6, 2022
|
R01
|
| Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research |
NOT-MH-22-100 |
NIMH
|
Jan 19, 2022 |
Jan 8, 2025
|
R21, R34, R01
|
| Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research |
NOT-MH-22-100 |
NIMH
|
Jan 19, 2022 |
Jan 8, 2025
|
R21, R34, R01
|
| Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases |
NOT-AR-22-012 |
NIAMS
|
Dec 28, 2021 |
Jan 8, 2023
|
R21, R01
|
| Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NOT-MD-22-006 |
NIMHD,
ODP,
NIDA,
NIAID,
SGMRO,
NIMH,
ORWH,
NINR,
NCI,
NIDCR,
OBSSR
|
Dec 21, 2021 |
Jan 8, 2023
|
R01
|
| Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection |
NOT-HL-22-004 |
NHLBI,
NICHD,
NIAID
|
Dec 21, 2021 |
Sep 8, 2025
|
R01, R21
|
| Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NOT-AA-22-002 |
NIAAA
|
Dec 2, 2021 |
May 8, 2024
|
333
|
| Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) |
NOT-OD-22-030 |
ORWH,
NIDA,
NEI,
NIDCD,
NIEHS,
NHGRI,
NIMH,
NIAID,
NINR,
NICHD,
NHLBI,
NCCIH,
NIAAA,
SGMRO,
NCATS,
NIDCR,
NIAMS,
ORIP,
NIDDK,
NIBIB,
NIA
|
Dec 2, 2021 |
Jan 27, 2023
|
333
|
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations |
NOT-MH-21-330 |
NIMH,
NEI,
ODP,
SGMRO,
NIDA,
OBSSR,
NIAAA,
NINR,
NIDCR,
NIMHD,
ORWH,
NICHD,
NIDCD,
NIA,
NCCIH
|
Aug 20, 2021 |
Sep 8, 2024
|
R01, UG3/UH3
|
| Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations |
NOT-MH-21-330 |
NIMH,
NEI,
ODP,
SGMRO,
NIDA,
OBSSR,
NIAAA,
NINR,
NIDCR,
NIMHD,
ORWH,
NICHD,
NIDCD,
NIA,
NCCIH
|
Aug 20, 2021 |
Sep 8, 2024
|
R01, UG3/UH3
|
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
PAR-21-276 |
NIAID
|
Jul 16, 2021 |
Jul 16, 2022
|
S10
|
| Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities |
NOT-HD-21-038 |
NICHD
|
Jun 28, 2021 |
May 8, 2024
|
R03, R21
|
| Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide |
NOT-AI-21-057 |
NIAID,
NIMH,
NIDA
|
Jun 25, 2021 |
May 8, 2024
|
R01, R21
|
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs |
NOT-TR-21-022 |
NCATS
|
Feb 26, 2021 |
Aug 17, 2024
|
333
|
| Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration |
NOT-AG-21-016 |
NIA
|
Feb 26, 2021 |
May 8, 2023
|
R01, R21, R03
|
| Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders |
NOT-DA-21-019 |
NIDA
|
Feb 10, 2021 |
Sep 8, 2024
|
R01, R03, R21
|
| Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 |
NOT-DA-21-017 |
NIDA
|
Feb 4, 2021 |
Sep 8, 2024
|
R01, R03, R21
|
| Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) |
NOT-AI-21-008 |
NIAID
|
Feb 4, 2021 |
Jan 8, 2023
|
R01, R21
|
| Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders |
NOT-DA-21-018 |
NIDA
|
Feb 3, 2021 |
Sep 8, 2024
|
R01, R03, R21
|
| Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs |
NOT-TR-21-017 |
NCATS
|
Feb 3, 2021 |
Aug 17, 2024
|
333
|
| Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) |
NOT-DE-21-001 |
NIDCR
|
Jan 26, 2021 |
May 8, 2023
|
R01, R21
|
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection |
NOT-DA-21-011 |
NIDA
|
Jan 26, 2021 |
Sep 8, 2024
|
R01, R03, R21
|
| Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research |
NOT-MH-21-120 |
NIMH
|
Dec 23, 2020 |
Jun 2, 2023
|
333
|
| RESCINDED - Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection |
NOT-DA-20-084 |
NIDA
|
Oct 27, 2020 |
Sep 8, 2024
|
R01, R03, R21
|
| Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) |
NOT-HL-20-814 |
NHLBI
|
Sep 15, 2020 |
Jul 6, 2024
|
R01
|
| Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
NOT-MD-20-025 |
NIMHD,
NCI,
NIDA,
NLM,
ODP,
OBSSR,
NIMH,
NIAMS
|
Aug 13, 2020 |
May 8, 2023
|
R01
|
| Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders |
NOT-DC-20-008 |
NIDCD
|
Jun 4, 2020 |
Sep 8, 2022
|
R01, R21, R41/R42, R43/R44
|
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
PA-20-135 |
NIH,
NCATS,
NCCIH,
NCI,
NHGRI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDCD,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINR,
NLM,
ORWH,
OSC
|
Mar 10, 2020 |
Sep 8, 2025
|
333
|
Expired Funding Opportunities
| Title |
Notice Number |
Organization(s) |
Release
Date |
Expiration
Date |
Activity
Code(s) |
| Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) |
NOT-DK-22-018 |
NIDDK
|
Mar 23, 2022 |
n/a
|
|
| Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) |
RFA-OD-22-005 |
OD,
NCATS,
NCCIH,
NCI,
NEI,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NINR
|
Feb 17, 2022 |
May 3, 2022
|
U01 |
| Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) |
RFA-OD-22-006 |
OD,
NCATS,
NCCIH,
NCI,
NEI,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NINR
|
Feb 17, 2022 |
May 3, 2022
|
U01 |
| Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) |
RFA-NR-22-001 |
NINR,
NIDA,
NIMH,
NIMHD,
OBSSR,
ODP
|
Jan 25, 2022 |
Apr 8, 2022
|
R01 |
| HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) |
RFA-DE-22-011 |
NIDCR,
NCATS,
NCCIH,
NCI,
NIA,
NIAMS,
NICHD
|
Jan 21, 2022 |
Apr 1, 2022
|
R21 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies |
NOT-GM-22-026 |
NIGMS
|
Jan 21, 2022 |
Mar 22, 2022
|
333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) |
NOT-NR-22-004 |
NINR,
NIMH,
ODP,
OBSSR,
NIDA,
NIMHD
|
Dec 17, 2021 |
n/a
|
|
| Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection |
NOT-OD-22-038 |
OD,
ORWH,
NCI,
NIA,
NIAAA,
NIADD,
NIAID,
NIAMS,
NIGMS,
NCATS,
NEI,
NHGRI,
NHLBI,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NINDS,
NIMHD,
NINR,
NLM,
ODP,
ORIP,
NCCIH,
NIMH
|
Dec 7, 2021 |
Jan 25, 2022
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) |
NOT-MD-22-001 |
NIMHD,
NIDA
|
Oct 25, 2021 |
Feb 2, 2022
|
333 |
| Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) |
RFA-HD-22-009 |
NICHD
|
Aug 25, 2021 |
Nov 30, 2021
|
P01 |
| Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 |
NOT-HD-21-037 |
NICHD
|
Jul 2, 2021 |
May 8, 2022
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) |
NOT-MD-21-020 |
NIMHD
|
May 27, 2021 |
Jul 16, 2021
|
333 |
| Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) |
RFA-DA-22-001 |
NIDA
|
Apr 27, 2021 |
Aug 14, 2021
|
R43/R44 |
| Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus |
NOT-DA-21-041 |
NIDA
|
Apr 15, 2021 |
Mar 31, 2022
|
333 |
| Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) |
RFA-OD-21-009 |
NIH,
NLM,
NIAID,
ECHO,
NICHD,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NHGRI,
NIAMS,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NINDS,
NINR,
NIA,
NIAAA,
NIDCD,
NIDA,
NIMHD,
OBSSR,
ODP,
ORWH,
SGMRO,
THRO,
NIBIB
|
Apr 13, 2021 |
Jul 8, 2021
|
U01 |
| Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake |
NOT-OD-21-101 |
NIH,
NIMH,
NIDDK,
NICHD,
NCI,
NCATS,
NCCIH,
NHLBI,
NIEHS,
NIGMS,
NINR,
NIA,
NIAAA,
NIDA,
NIMHD,
NLM,
NIAID
|
Apr 13, 2021 |
May 4, 2021
|
333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional) |
NOT-OD-21-103 |
NIH,
NIDCD,
ECHO,
NICHD,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NHGRI,
NIAID,
NIAMS,
NIBIB,
NIDCR,
NIEHS,
NIGMS,
NIMH,
NINDS,
NINR,
NIA,
NIAAA,
NIDA,
NIMHD,
NLM,
OBSSR,
ODP,
ORWH,
SGMRO,
THRO,
NIDDK
|
Apr 13, 2021 |
May 25, 2021
|
U01 |
| Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) |
RFA-OD-21-008 |
NIH,
NIBIB,
NIDDK,
NIEHS,
NIMH,
NINDS,
NINR,
NIA,
NIAAA,
NIDCD,
NIDA,
NIMHD,
NLM,
OBSSR,
ODP,
SGMRO,
THRO,
NIDCR,
NHLBI,
ECHO,
NICHD,
NCI,
NCATS,
NCCIH,
NEI,
NHGRI,
NIAID,
NIAMS,
NIGMS,
ORWH
|
Apr 13, 2021 |
Jul 8, 2021
|
U01 |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) |
RFA-AG-21-035 |
NIA,
ORWH,
OBSSR
|
Apr 8, 2021 |
Jun 10, 2021
|
U24 |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) |
PAR-21-213 |
NIA,
NEI,
NIAAA,
NIDA,
NIMH,
NIMHD,
NINR,
OBSSR,
ORWH
|
Apr 6, 2021 |
Nov 9, 2021
|
U01 |
| Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries |
NOT-TW-21-004 |
FIC
|
Mar 23, 2021 |
May 15, 2021
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards |
NOT-TW-21-003 |
FIC
|
Mar 23, 2021 |
May 15, 2021
|
333 |
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II) |
NOT-OD-21-064 |
NIH,
ORWH
|
Mar 22, 2021 |
n/a
|
|
| Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations |
NOT-NS-21-037 |
NINDS
|
Mar 15, 2021 |
May 6, 2021
|
333 |
| Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations |
NOT-NS-21-037 |
NINDS
|
Mar 15, 2021 |
May 6, 2021
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy |
NOT-GM-21-032 |
NIGMS
|
Mar 10, 2021 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy |
NOT-GM-21-032 |
NIGMS
|
Mar 10, 2021 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19 |
NOT-OD-21-071 |
NIH
|
Mar 5, 2021 |
Apr 14, 2021
|
333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy |
NOT-GM-21-021 |
NIGMS,
SGMRO
|
Mar 1, 2021 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy |
NOT-GM-21-021 |
NIGMS,
SGMRO
|
Mar 1, 2021 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NOT-GM-21-019 |
NIGMS
|
Feb 25, 2021 |
Dec 16, 2021
|
333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NOT-GM-21-019 |
NIGMS
|
Feb 25, 2021 |
Dec 16, 2021
|
333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies |
NOT-GM-21-031 |
NIGMS
|
Feb 18, 2021 |
Apr 1, 2021
|
333 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) |
RFA-AA-21-003 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R03 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) |
RFA-AA-21-003 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R03 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) |
RFA-AA-21-002 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R01 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) |
RFA-AA-21-002 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R01 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) |
RFA-AA-21-004 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R21 |
| SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) |
RFA-AA-21-004 |
NIAAA
|
Feb 5, 2021 |
Aug 18, 2021
|
R21 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation |
NOT-MD-21-012 |
NIMHD
|
Feb 4, 2021 |
May 4, 2021
|
333 |
| Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control |
NOT-CA-21-033 |
NCI
|
Feb 3, 2021 |
Apr 1, 2021
|
333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) |
NOT-AA-21-003 |
NIAAA
|
Jan 27, 2021 |
Feb 28, 2021
|
|
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) |
NOT-AA-21-003 |
NIAAA
|
Jan 27, 2021 |
Feb 28, 2021
|
|
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed) |
NOT-AA-21-002 |
NIAAA
|
Jan 27, 2021 |
Feb 3, 2021
|
|
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) |
NOT-AA-21-001 |
NIAAA
|
Jan 27, 2021 |
Feb 28, 2021
|
|
| Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) |
NOT-AA-21-001 |
NIAAA
|
Jan 27, 2021 |
Feb 28, 2021
|
|
| Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) |
NOT-AG-21-015 |
NIA
|
Jan 26, 2021 |
Sep 10, 2021
|
R01,R03,R21,U19,P01,R21/R33 |
| Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
RFA-AI-20-078 |
NIAID,
NICHD,
NIEHS
|
Jan 12, 2021 |
Jun 19, 2021
|
U19 |
| Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
RFA-AI-20-077 |
NIAID,
NICHD,
NIEHS
|
Jan 12, 2021 |
Jun 19, 2021
|
U01 |
| Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases |
NOT-AR-21-012 |
NIAMS
|
Jan 5, 2021 |
Nov 19, 2021
|
R01,R21 |
| RESCINDED - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NOT-MD-21-008 |
NIMHD,
NCI,
NHLBI,
NIAAA,
NIAID,
NIAMS,
NIDCR,
NIMH,
NINR,
OBSSR,
ODP,
ORWH
|
Dec 17, 2020 |
Jan 8, 2022
|
R01 |
| Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs |
NOT-TR-21-011 |
NCATS
|
Dec 17, 2020 |
Jun 2, 2021
|
333 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts |
NOT-HG-21-020 |
NHGRI
|
Dec 10, 2020 |
Jan 16, 2021
|
333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NOT-MD-21-007 |
NIMHD
|
Dec 7, 2020 |
Dec 31, 2020
|
|
| Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) |
NOT-OD-21-035 |
NIH,
NIDCR,
NHLBI
|
Nov 25, 2020 |
Dec 5, 2020
|
333 |
| Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) |
NOT-OD-21-020 |
NIH,
NLM,
NIEHS,
NIAMS,
NIDCR,
OBSSR,
NIGMS,
NHLBI,
NCI,
NIAAA,
NINR,
NCATS,
ORWH,
NHGRI,
FIC,
NCCIH,
NIMH,
THRO,
NIDA,
NINDS,
NEI,
NIMHD,
NIAID,
NIA,
FDA,
NIBIB,
NIDCD,
NICHD,
NIDDK
|
Nov 17, 2020 |
Mar 5, 2021
|
333 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-21-002 |
NIEHS
|
Nov 17, 2020 |
Dec 30, 2020
|
333 |
| Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-21-002 |
NIEHS
|
Nov 17, 2020 |
Dec 30, 2020
|
333 |
| Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects |
NOT-AI-21-002 |
NIAID
|
Nov 10, 2020 |
Jun 12, 2021
|
P01 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-21-006 |
NCATS
|
Oct 23, 2020 |
Mar 17, 2021
|
UH2,U34,U01 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-21-006 |
NCATS
|
Oct 23, 2020 |
Mar 17, 2021
|
UH2,U34,U01 |
| Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 |
NOT-AI-20-065 |
NIAID
|
Aug 13, 2020 |
Mar 15, 2021
|
U01 |
| Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with
Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) |
RFA-OD-20-023 |
NIH,
FIC,
NCATS,
NHLBI,
NIAID,
NIAMS,
NICHD,
NIDA,
NIMHD
|
Aug 6, 2020 |
Oct 1, 2020
|
R61/R33 |
| Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) |
RFA-OD-20-022 |
NIH,
NIA,
NIDCD,
ORWH,
NICHD,
NLM,
NINR,
NINDS,
NIDCR
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) |
RFA-OD-20-021 |
NIH,
NIAAA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
R42 |
| Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) |
RFA-OD-20-020 |
NIH,
NIAAA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
R44 |
| Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) |
RFA-OD-20-019 |
NIH,
NIAAA,
NIA,
NCCIH,
NIDCD,
NIDDK,
NIEHS,
NIGMS,
NICHD,
NIMHD,
NLM,
NINR,
NCATS,
OBSSR,
NHLBI,
NIDCR,
NIDA
|
Aug 6, 2020 |
Oct 1, 2020
|
U24 |
| Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) |
RFA-OD-20-018 |
NIH,
NIA,
NCI,
RM,
NCATS,
NHLBI,
NIDCR,
NIDA,
NHGRI
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
| Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) |
RFA-OD-20-018 |
NIH,
NIA,
NCI,
RM,
NCATS,
NHLBI,
NIDCR,
NIDA,
NHGRI
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
| Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) |
RFA-OD-20-017 |
NIH,
NIAAA,
NIA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
| Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) |
RFA-OD-20-016 |
NIH,
NIAAA,
NIDDK,
NIGMS,
NIMHD,
NLM,
NINR,
OBSSR,
NIDCR,
NIDA
|
Aug 6, 2020 |
Oct 1, 2020
|
R01 |
| Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) |
RFA-OD-20-015 |
NIH,
NIEHS,
NIGMS,
NLM,
NIDA
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
| Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) |
RFA-OD-20-014 |
NIH,
NIAAA,
NIA,
NCCIH,
NCI,
NICHD
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool |
NOT-OD-20-152 |
NIH,
NIA,
NIDCD,
ORWH,
NICHD,
NINR,
NINDS,
NIDCR
|
Aug 6, 2020 |
Sep 16, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). |
NOT-OD-20-159 |
NIH,
NLM
|
Aug 6, 2020 |
Aug 22, 2020
|
333 |
| Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) |
RFA-TR-20-003 |
NCATS
|
Aug 5, 2020 |
Jan 24, 2021
|
U01 |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
PAR-20-256 |
NIAID
|
Jul 13, 2020 |
Jul 8, 2021
|
S10 |
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative |
NOT-OD-20-144 |
NIH,
NIDCD
|
Jul 10, 2020 |
Aug 6, 2020
|
|
| Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
RFA-DK-20-021 |
NIDDK
|
Jul 10, 2020 |
Dec 17, 2020
|
R01 |
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-059 |
NIAID
|
Jul 6, 2020 |
Jul 2, 2021
|
333 |
| Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-082 |
NCI
|
Jul 6, 2020 |
Aug 15, 2020
|
333 |
| Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) |
PAR-20-243 |
NIMH,
NCCIH,
NEI,
NIA,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIMHD,
NINR,
OBSSR,
ODP,
ORWH
|
Jun 25, 2020 |
Mar 3, 2021
|
R01 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project |
NOT-OD-20-129 |
NIH,
NCATS,
NCCIH,
NCI,
NHGRI,
NHLBI,
NIAID,
NIAMS,
NICHD,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIMHD,
NINDS,
ORIP
|
Jun 25, 2020 |
Jul 13, 2021
|
333 |
| Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers |
NOT-CA-20-077 |
NCI
|
Jun 25, 2020 |
Jul 31, 2020
|
|
| Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) |
PAR-20-237 |
NIMHD,
NIDCD,
NIMH,
ODP,
NINR,
NIA,
SGMRO,
NIDDK,
NIEHS,
NICHD,
NCATS,
ORWH,
NIAAA,
NCCIH,
NIDA,
NEI,
NIDCR
|
Jun 17, 2020 |
Dec 2, 2020
|
R01 |
| Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need |
NOT-TR-20-029 |
NCATS
|
Jun 15, 2020 |
Nov 11, 2020
|
333 |
| NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) |
PAR-20-234 |
NIA
|
Jun 15, 2020 |
Feb 2, 2021
|
R01 |
| Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-121 |
NIH,
NIDCR,
NICHD,
NCI,
NCATS,
NEI,
NHLBI,
NIAID,
NIAMS,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIAAA,
NIDA,
NIMHD,
ORWH,
OBSSR,
NLM,
SGMRO,
THRO,
NIA,
NCCIH,
ODP
|
Jun 12, 2020 |
Aug 8, 2020
|
333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-120 |
NIH,
NIAID,
NIBIB,
NIDCR,
NIMHD,
NICHD,
NIAMS,
FIC,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIAAA,
NIA,
NIDCD,
NIDA,
ORWH,
OBSSR,
ODP,
NLM,
SGMRO,
THRO
|
Jun 12, 2020 |
Sep 9, 2020
|
333 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-119 |
NIH,
NICHD,
FIC,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAID,
NIAMS,
NIBIB,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIA,
NIAAA,
NIDA,
NIMHD,
ORWH,
ODP,
NLM,
SGMRO,
THRO,
NIDCD,
OBSSR
|
Jun 12, 2020 |
Sep 9, 2020
|
333 |
| Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) |
RFA-OD-20-013 |
NIH,
NCI,
NIAMS,
NIA,
NICHD,
FIC,
NCATS,
NCCIH,
NEI,
NHLBI,
NIBIB,
NIDCR,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINR,
NIDCD,
NIDA,
NIMHD,
ORWH,
OBSSR,
NLM,
SGMRO,
THRO,
ODP
|
Jun 12, 2020 |
Aug 8, 2020
|
U24 |
| Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) |
RFA-CA-20-038 |
NCI,
NIAID
|
Jun 5, 2020 |
Jul 23, 2020
|
U54 |
| Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) |
RFA-CA-20-039 |
NCI,
NIAID
|
Jun 5, 2020 |
Jul 23, 2020
|
U01 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations |
NOT-MD-20-022 |
NIMHD,
ORWH,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIMH,
OBSSR,
ODP
|
Jun 5, 2020 |
Dec 30, 2020
|
333 |
| Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 |
NOT-MH-20-053 |
NIMH,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NINR,
OBSSR,
ODP,
ORWH
|
Jun 5, 2020 |
Dec 30, 2020
|
333 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) |
NOT-MH-20-058 |
NIMH,
NIAAA,
NIA,
NCCIH,
NIDCD,
NICHD,
NINR,
OBSSR,
ODP,
NIDCR,
NIDA,
NEI
|
Jun 4, 2020 |
Jun 26, 2020
|
|
| Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) |
NOT-MD-20-023 |
NIMHD,
NIDCD,
OBSSR,
NIDA,
NINR,
ODP,
NCCIH,
NIMH,
NIDCR,
NIEHS,
NIA,
NICHD,
ORWH
|
Jun 3, 2020 |
Jun 17, 2020
|
|
| Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives |
NOT-OD-20-112 |
NIH
|
May 29, 2020 |
Jun 26, 2020
|
|
| Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research |
NOT-OD-20-107 |
NIH
|
May 27, 2020 |
Jun 30, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) |
NOT-AT-20-012 |
NCCIH
|
May 26, 2020 |
Aug 18, 2020
|
333 |
| NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) |
RFA-RM-20-020 |
RMOD
|
May 21, 2020 |
Oct 1, 2020
|
R01 |
| NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) |
RFA-RM-20-021 |
RMOD
|
May 21, 2020 |
Sep 5, 2020
|
DP5 |
| Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-051 |
NIAID
|
May 19, 2020 |
Sep 8, 2020
|
R03,R43/R44,R41/R42 |
| Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence |
NOT-CA-20-066 |
NCI
|
May 15, 2020 |
Jun 5, 2020
|
|
| Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR |
NOT-DE-20-022 |
NIDCR,
ORWH
|
May 5, 2020 |
Nov 3, 2020
|
333 |
| Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network |
NOT-DE-20-023 |
NIDCR
|
May 1, 2020 |
Nov 3, 2020
|
X01 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System |
NOT-NS-20-051 |
NINDS
|
Apr 30, 2020 |
Apr 15, 2021
|
333 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) |
PAR-20-177 |
NIAID
|
Apr 30, 2020 |
Aug 14, 2020
|
R21 |
| Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) |
PAR-20-178 |
NIAID
|
Apr 30, 2020 |
Aug 14, 2020
|
R01 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials |
NOT-HL-20-782 |
NHLBI
|
Apr 27, 2020 |
Oct 6, 2020
|
333 |
| Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) |
NOT-LM-20-011 |
NLM
|
Apr 27, 2020 |
Jun 17, 2020
|
R21 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-RM-20-015 |
RMOD
|
Apr 27, 2020 |
Jun 20, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs |
NOT-TR-20-028 |
NCATS
|
Apr 23, 2020 |
Nov 11, 2020
|
333 |
| Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NOT-AA-20-011 |
NIAAA
|
Apr 16, 2020 |
Apr 16, 2021
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) |
NOT-LM-20-010 |
NLM
|
Apr 16, 2020 |
Jun 2, 2020
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences |
NOT-OD-20-097 |
OBSSR,
NCCIH,
NCI,
NHGRI,
NHLBI,
NIAAA,
NICHD,
NIDDK,
NIEHS,
NINR,
ODP,
ORWH
|
Apr 13, 2020 |
Apr 1, 2021
|
333 |
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NOT-ES-20-020 |
NIEHS
|
Apr 10, 2020 |
May 4, 2021
|
333,R21 |
| Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-007 |
NIBIB
|
Apr 10, 2020 |
Aug 29, 2020
|
R01,R21,R03 |
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 |
NOT-GM-20-027 |
NIGMS
|
Apr 10, 2020 |
May 6, 2020
|
333 |
| NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) |
NOT-ES-20-017 |
NIEHS
|
Apr 10, 2020 |
Apr 25, 2020
|
333 |
| Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-006 |
NIBIB
|
Apr 10, 2020 |
Sep 6, 2020
|
R41/R42,R43/R44 |
| Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-008 |
NIBIB
|
Apr 10, 2020 |
Aug 29, 2020
|
333 |
| Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 |
NOT-NS-20-046 |
NINDS
|
Apr 10, 2020 |
May 9, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission |
NOT-DK-20-020 |
NIDDK
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities |
NOT-MD-20-019 |
NIMHD,
NIAAA,
NIMH,
ODP
|
Apr 9, 2020 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus |
NOT-TR-20-017 |
NCATS
|
Apr 9, 2020 |
Jan 26, 2022
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus |
NOT-MH-20-047 |
NIMH,
NIAAA,
ODP
|
Apr 9, 2020 |
Apr 16, 2021
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus |
NOT-TR-20-016 |
NCATS
|
Apr 9, 2020 |
Jan 26, 2022
|
333 |
| Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-043 |
NCI
|
Apr 9, 2020 |
Jun 26, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK |
NOT-DK-20-018 |
NIDDK
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) |
NOT-DC-20-004 |
NIDCD
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) |
NOT-AT-20-011 |
NCCIH,
NIA,
NIAAA,
ODP
|
Apr 9, 2020 |
Oct 7, 2020
|
333 |
| Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-042 |
NCI
|
Apr 9, 2020 |
Jun 26, 2020
|
333 |
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NOT-ES-20-015 |
NIEHS
|
Apr 8, 2020 |
May 4, 2021
|
333,R21 |
| Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-AG-20-022 |
NIAAA,
NIMH
|
Apr 2, 2020 |
May 1, 2021
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus |
NOT-HG-20-030 |
NHGRI
|
Mar 31, 2020 |
May 16, 2020
|
333 |
| Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-20-012 |
NCATS
|
Mar 27, 2020 |
Oct 17, 2020
|
UH2,U01,U34 |
| RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-031 |
NIAID
|
Mar 27, 2020 |
Apr 5, 2021
|
R03,R21,333,R01,R43/R44,R41/R42 |
| RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) |
NOT-ES-20-014 |
NIEHS
|
Mar 27, 2020 |
Apr 25, 2020
|
333 |
| RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-034 |
NIAID
|
Mar 25, 2020 |
Jul 6, 2020
|
333 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NOT-GM-20-025 |
NIGMS
|
Mar 25, 2020 |
Feb 6, 2021
|
333 |
| Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need |
NOT-TR-20-011 |
NCATS
|
Mar 24, 2020 |
Jul 10, 2021
|
333,U01,R21,U54 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus |
NOT-DA-20-047 |
NIDA
|
Mar 19, 2020 |
Mar 31, 2021
|
333 |
| RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-HL-20-757 |
NHLBI
|
Mar 17, 2020 |
May 15, 2020
|
333 |
| RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) |
NOT-AI-20-030 |
NIAID,
NIGMS
|
Feb 6, 2020 |
Apr 8, 2020
|
333 |
| Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) |
NOT-OD-20-048 |
ORWH,
NCATS,
NCCIH,
NCI,
NEI,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NINR,
NLM,
OD
|
Dec 13, 2019 |
Jan 26, 2021
|
333 |
| The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
RFA-OD-19-029 |
ORWH,
NCCIH,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIDA,
NIDCR,
NIEHS,
NIMH,
NINR
|
Sep 27, 2019 |
Nov 27, 2021
|
R01 |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
